Kairos Pharma Stock Forecast - Accumulation Distribution
| KAPA Stock | 0.72 0 0.18% |
Kairos Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Kairos Pharma stock prices and determine the direction of Kairos Pharma's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Kairos Pharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time, the RSI of Kairos Pharma's share price is approaching 41. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Kairos Pharma, making its price go up or down. Momentum 41
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.07) | EPS Estimate Current Year (0.20) | EPS Estimate Next Year (0.33) | Wall Street Target Price 8.3333 |
Using Kairos Pharma hype-based prediction, you can estimate the value of Kairos Pharma from the perspective of Kairos Pharma response to recently generated media hype and the effects of current headlines on its competitors.
Kairos Pharma after-hype prediction price | USD 0.48 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Kairos Pharma to cross-verify your projections. Kairos Pharma Additional Predictive Modules
Most predictive techniques to examine Kairos price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Kairos using various technical indicators. When you analyze Kairos charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Kairos Pharma Volatility | Backtest Kairos Pharma | Information Ratio |
Kairos Pharma Trading Date Momentum
| On January 27 2026 Kairos Pharma was traded for 0.72 at the closing time. The top price for the day was 0.72 and the lowest listed price was 0.72 . There was no trading activity during the period 0.0. Lack of trading volume on January 27, 2026 did not cause price change. The trading delta at closing time against the current closing price is 0.18% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Kairos Pharma to competition |
Other Forecasting Options for Kairos Pharma
For every potential investor in Kairos, whether a beginner or expert, Kairos Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Kairos Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Kairos. Basic forecasting techniques help filter out the noise by identifying Kairos Pharma's price trends.Kairos Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Kairos Pharma stock to make a market-neutral strategy. Peer analysis of Kairos Pharma could also be used in its relative valuation, which is a method of valuing Kairos Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Kairos Pharma Market Strength Events
Market strength indicators help investors to evaluate how Kairos Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kairos Pharma shares will generate the highest return on investment. By undertsting and applying Kairos Pharma stock market strength indicators, traders can identify Kairos Pharma entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 0.72 | |||
| Day Typical Price | 0.72 | |||
| Price Action Indicator | (0) | |||
| Period Momentum Indicator | (0) | |||
| Relative Strength Index | 41.3 |
Kairos Pharma Risk Indicators
The analysis of Kairos Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Kairos Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting kairos stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.43 | |||
| Standard Deviation | 5.81 | |||
| Variance | 33.76 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Kairos Pharma
The number of cover stories for Kairos Pharma depends on current market conditions and Kairos Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Kairos Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Kairos Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Kairos Pharma Short Properties
Kairos Pharma's future price predictability will typically decrease when Kairos Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Kairos Pharma often depends not only on the future outlook of the potential Kairos Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kairos Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 11.4 M | |
| Cash And Short Term Investments | 1.3 M |
Check out Historical Fundamental Analysis of Kairos Pharma to cross-verify your projections. For information on how to trade Kairos Stock refer to our How to Trade Kairos Stock guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kairos Pharma. If investors know Kairos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kairos Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Kairos Pharma is measured differently than its book value, which is the value of Kairos that is recorded on the company's balance sheet. Investors also form their own opinion of Kairos Pharma's value that differs from its market value or its book value, called intrinsic value, which is Kairos Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kairos Pharma's market value can be influenced by many factors that don't directly affect Kairos Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kairos Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kairos Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kairos Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.